|
1
|
Rochette L, Guenancia C, Gudjoncik A,
Hachet O, Zeller M, Cottin Y and Vergely C:
Anthracyclines/trastuzumab: New aspects of cardiotoxicity and
molecular mechanisms. Trends Pharmacol Sci. 36:326–348. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stone JB and DeAngelis LM:
Cancer-treatment-induced neurotoxicity-focus on newer treatments.
Nat Rev Clin Oncol. 13:92–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suter TM and Ewer MS: Cancer drugs and the
heart: Importance and management. Eur Heart J. 34:1102–1111. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Franco VI, Henkel JM, Miller TL and
Lipshultz SE: Cardiovascular effects in childhood cancer survivors
treated with anthracyclines. Cardiol Res Pract. 2011:1346792011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Volkova M and Russell R III: Anthracycline
cardiotoxicity: Prevalence, pathogenesis and treatment. Curr
Cardiol Rev. 7:214–220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ezquer F, Gutiérrez J, Ezquer M, Caglevic
C, Salgado HC and Calligaris SD: Mesenchymal stem cell therapy for
doxorubicin cardiomyopathy: Hopes and fears. Stem Cell Res Ther.
6:1162015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu Q, Li Q, Na R, Li X, Liu B, Meng L,
Liutong H, Fang W, Zhu N and Zheng X: Impact of repeated
intravenous bone marrow mesenchymal stem cells infusion on
myocardial collagen network remodeling in a rat model of
doxorubicin-induced dilated cardiomyopathy. Mol Cell Biochem.
387:279–285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garbade J, Dhein S, Lipinski C, Aupperle
H, Arsalan M, Borger MA, Barten MJ, Lehmann S, Walther T and Mohr
FW: Bone marrow-derived stem cells attenuate impaired contractility
and enhance capillary density in a rabbit model of
Doxorubicin-induced failing hearts. J Card Surg. 24:591–599. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eulalio A, Mano M, Dal Ferro M, Zentilin
L, Sinagra G, Zacchigna S and Giacca M: Functional screening
identifies miRNAs inducing cardiac regeneration. Nature.
492:376–381. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Seeger FH, Zeiher AM and Dimmeler S:
MicroRNAs in stem cell function and regenerative therapy of the
heart. Arterioscler Thromb Vasc Biol. 33:1739–1746. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Y, Cheng HW, Qiu Y, Dupee D, Noonan
M, Lin YD, Fisch S, Unno K, Sereti KI and Liao R: MicroRNA-34a
plays a key role in cardiac repair and regeneration following
myocardial infarction. Circ Res. 117:450–459. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boon RA, Iekushi K, Lechner S, Seeger T,
Fischer A, Heydt S, Kaluza D, Tréguer K, Carmona G, Bonauer A, et
al: MicroRNA-34a regulates cardiac ageing and function. Nature.
495:107–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen F and Hu SJ: Effect of microRNA-34a
in cell cycle, differentiation, and apoptosis: A review. J Biochem
Mol Toxicol. 26:79–86. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Piegari E, Russo R, Cappetta D, Esposito
G, Urbanek K, Dell'Aversana C, Altucci L, Berrino L, Rossi F and De
Angelis A: MicroRNA-34a regulates doxorubicin-induced
cardiotoxicity in rat. Oncotarget. 7:62312–62326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haigis MC and Sinclair DA: Mammalian
sirtuins: Biological insights and disease relevance. Annu Rev
Pathol. 5:253–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morris BJ: Seven sirtuins for seven deadly
diseases of aging. Free Radic Biol Med. 56:133–171. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Deng CX: SIRT1, is it a tumor promoter or
tumor suppressor? Int J Biol Sci. 5:147–152. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo J, Nikolaev AY, Imai S, Chen D, Su F,
Shiloh A, Guarente L and Gu W: Negative control of p53 by Sir2alpha
promotes cell survival under stress. Cell. 107:137–148. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang G, Zhang X, Weng X, Liang P, Dai X,
Zeng S, Xu H, Huan H, Fang M, Li Y, et al: SUV39H1 mediated SIRT1
trans-repression contributes to cardiac ischemia-reperfusion
injury. Basic Res Cardiol. 112:222017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
De Angelis A, Piegari E, Cappetta D, Russo
R, Esposito G, Ciuffreda LP, Ferraiolo FA, Frati C, Fagnoni F,
Berrino L, et al: SIRT1 activation rescues doxorubicin-induced loss
of functional competence of human cardiac progenitor cells. Int J
Cardiol. 189:30–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu WH, Liu JJ, Wu J, Zhang LL, Liu F, Yin
L, Zhang MM and Yu B: Novel mechanism of inhibition of dendritic
cells maturation by mesenchymal stem cells via interleukin-10 and
the JAK1/STAT3 signaling pathway. PLoS One. 8:e554872013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xia W, Zhang F, Xie C, Jiang M and Hou M:
Macrophage migration inhibitory factor confers resistance to
senescence through CD74-dependent AMPK-FOXO3a signaling in
mesenchymal stem cells. Stem Cell Res Ther. 6:822015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xia W, Xie C, Jiang M and Hou M: Improved
survival of mesenchymal stem cells by macrophage migration
inhibitory factor. Mol Cell Biochem. 404:11–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Crepin T, Carron C, Roubiou C, Gaugler B,
Gaiffe E, Simula-Faivre D, Ferrand C, Tiberghien P, Chalopin JM,
Moulin B, et al: ATG-induced accelerated immune senescence:
Clinical implications in renal transplant recipients. Am J
Transplant. 15:1028–1038. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang F, Cui J, Liu X, Lv B, Liu X, Xie Z
and Yu B: Roles of microRNA-34a targeting SIRT1 in mesenchymal stem
cells. Stem Cell Res Ther. 6:1952015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bao Y, Yin M, Hu X, Zhuang X, Sun Y, Guo
Y, Tan S and Zhang Z: A safe, simple and efficient doxorubicin
prodrug hybrid micelle for overcoming tumor multidrug resistance
and targeting delivery. J Control Release. 235:182–194. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tanaka M, Koul D, Davies MA, Liebert M,
Steck PA and Grossman HB: MMAC1/PTEN inhibits cell growth and
induces chemosensitivity to doxorubicin in human bladder cancer
cells. Oncogene. 19:5406–5412. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu J, Mao W, Ding B and Liang CS:
ERKs/p53 signal transduction pathway is involved in
doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am
J Physiol Heart Circ Physiol. 295:H1956–H1965. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Burridge PW, Li YF, Matsa E, Wu H, Ong SG,
Sharma A, Holmström A, Chang AC, Coronado MJ, Ebert AD, et al:
Human induced pluripotent stem cell-derived cardiomyocytes
recapitulate the predilection of breast cancer patients to
doxorubicin-induced cardiotoxicity. Nat Med. 22:547–556. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Golpanian S, Wolf A, Hatzistergos KE and
Hare JM: Rebuilding the damaged heart: Mesenchymal stem cells,
cell-based therapy, and engineered heart tissue. Physiol Rev.
96:1127–1168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Samper E, Diez-Juan A, Montero JA and
Sepúlveda P: Cardiac cell therapy: Boosting mesenchymal stem cells
effects. Stem Cell Rev. 9:266–280. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao SL, Zhang YJ, Li MH, Zhang XL and
Chen SL: Mesenchymal stem cells with overexpression of midkine
enhance cell survival and attenuate cardiac dysfunction in a rat
model of myocardial infarction. Stem Cell Res Ther. 5:372014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Chen X, Cao W and Shi Y:
Plasticity of mesenchymal stem cells in immunomodulation:
Pathological and therapeutic implications. Nat Immunol.
15:1009–1016. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Creemers EE, Tijsen AJ and Pinto YM:
Circulating microRNAs: Novel biomarkers and extracellular
communicators in cardiovascular disease? Circ Res. 110:483–495.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang H, Han L, Zhao G, Shen H, Wang P, Sun
Z, Xu C, Su Y, Li G, Tong T and Chen J: hnRNP A1 antagonizes
cellular senescence and senescence-associated secretory phenotype
via regulation of SIRT1 mRNA stability. Aging cell. Sep
9–2016.(Epub ahead of print). View Article : Google Scholar
|
|
37
|
McCubbrey AL, Nelson JD, Stolberg VR,
Blakely PK, McCloskey L, Janssen WJ, Freeman CM and Curtis JL:
MicroRNA-34a negatively regulates efferocytosis by tissue
macrophages in part via SIRT1. 196:1366–1375. 2016.
|
|
38
|
Brunet A, Sweeney LB, Sturgill JF, Chua
KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, et
al: Stress-dependent regulation of FOXO transcription factors by
the SIRT1 deacetylase. Science. 303:2011–2015. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Motta MC, Divecha N, Lemieux M, Kamel C,
Chen D, Gu W, Bultsma Y, McBurney M and Guarente L: Mammalian SIRT1
represses forkhead transcription factors. Cell. 116:551–563. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao T, Li J and Chen AF: MicroRNA-34a
induces endothelial progenitor cell senescence and impedes its
angiogenesis via suppressing silent information regulator 1. Am J
Physiol Endocrinol Metab. 299:E110–E116. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiong H, Pang J, Yang H, Dai M, Liu Y, Ou
Y, Huang Q, Chen S, Zhang Z, Xu Y, et al: Activation of
miR-34a/SIRT1/p53 signaling contributes to cochlear hair cell
apoptosis: Implications for age-related hearing loss. Neurobiol
Aging. 36:1692–1701. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chan SR and Blackburn EH: Telomeres and
telomerase. Philos Trans R Soc Lond B Biol Sci. 359:109–121. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
de Lange T: Shelterin: The protein complex
that shapes and safeguards human telomeres. Genes Dev.
19:2100–2110. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mourkioti F, Kustan J, Kraft P, Day JW,
Zhao MM, Kost-Alimova M, Protopopov A, DePinho RA, Bernstein D,
Meeker AK and Blau HM: Role of telomere dysfunction in cardiac
failure in Duchenne muscular dystrophy. Nat Cell Biol. 15:895–904.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Boe AE, Eren M, Murphy SB, Kamide CE,
Ichimura A, Terry D, McAnally D, Smith LH, Miyata T and Vaughan DE:
Plasminogen activator inhibitor-1 antagonist TM5441 attenuates
Nomega-nitro-L-arginine methyl ester-induced hypertension and
vascular senescence. Circulation. 128:2318–2324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
De Bonis ML, Ortega S and Blasco MA: SIRT1
is necessary for proficient telomere elongation and genomic
stability of induced pluripotent stem cells. Stem Cell Reports.
2:690–706. 2014. View Article : Google Scholar : PubMed/NCBI
|
